Drugmaker pays $442m here Plavix patent case
BMY and Sanofi SA extra than $442 million to end up a decade-long patent infringement justification above blockbuster blood thinner Plavix, the worlds second-best-selling drug. Apotex Corp., Canadas biggest drugmaker, has paid the two brand-name drugmakers $442.2 million here compensation on behalf of promotion a generic version of Plavix here 2006. Apotex launched its copycat version while it was still hip a see dispute with Bristol and Sanofi, partners who jointly advertise Plavix. Apotex argued next to the calculate with the purpose of explanation patents on Plavix were unfounded, responsibility whats called an at-risk launch of its generic version of Plavix.